90% Of Patients Treated With Experimental Israeli COVID Drug Discharged Within 5 Days

Joyful man is cured of the disease and stands at the railway station in a medical mask

Zero Hedge: Finally, it looks like the world might be on the verge of obtaining a therapeutic drug that’s actually effective at helping patients infected with COVID. But you probably won’t hear anything about this latest breakthrough from the American media, which covered the race for a vaccine with breathless enthusiasm.

” … And in you all the families of the earth shall be blessed.” Genesis 12:3 

According to a report in the Jerusalem Post, some 93% of 90 seriously ill coronavirus patients treated in several Greek hospitals with a new drug developed by a team at Tel Aviv’s Sourasky Medical Center were discharged in five days or fewer during the Phase II trial of the new therapeutic.

The Phase II trial confirmed the results of Phase I, which was conducted in Israel last winter. That trial found that 29 out of 30 patients in moderate to serious condition recover within days, while no cases of serious side effects have yet been detected.

“The main goal of this study was to verify that the drug is safe,” Prof. Nadir Arber said. “To this day we have not registered any significant side effect in any patient from both groups.”

The scientists are preparing to begin the Phase 3 trial, which they hope to complete by the end of the year. That probably couldn’t happen quickly enough, since the world is already waking up to the fact that the vaccines originally marketed as more than 90% effective are actually helping the virus to mutate into more virulent strains. Read More